Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
  E-Commerce
  Information technology
  Internet
  Microelectronics and nanotechnology
  Multimedia
  Telecommunications
  Other
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belgium
  Benin
  Brazil
  Bulgaria
  Canada
  Chile
  China
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malta
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


   Success Stories

Last Update: 10-04-2013  
Related category(ies):
Innovation  |  Information society  |  Health & life sciences  |  Special Collections

 

Countries involved in the project described in the article:
United Kingdom
Add to PDF "basket"

European researchers make advances in HIV and cancer detection

A multidisciplinary EU-funded research team has successfully tested a pioneering HIV-detection technique that is ten times more sensitive than any identification method used to date. The new methodology, which offers a much simpler and cheaper naked-eye-based read-out and could be commercialised in future, has also achieved positive results in similar early detection tests for different types of cancer.


© Fotolia

The EU-funded MIMIC project is currently working towards a breakthrough in cancer diagnostics which is based on an ultra-sensitive detection system that is able to pick up minute concentrations of disease-related molecules in body fluids. The method it uses draws on the body's natural processes of biomineralisation – the production of minerals.

A similar diagnostic approach to that being used in MIMIC's cancer research has already proven effective in detecting HIV/AIDS. Dr Roberto de la Rica Quesada, the MIMIC project coordinator, and Professor Molly Stevens, a European Research Council grantee at Imperial College London, have successfully tested a pioneering HIV-detection technique that is ten times more sensitive than any identification method used to date.

This HIV breakthrough is a triumph for the diagnostic approach MIMIC first developed for cancer detection, which went through a number of stages of development and design before successful results were achieved.

The project plan originally involved the recreation of bone mineralisation conditions in order to fabricate ultra-sensitive sensors via the production of calcium phosphate crystals. By adding antibodies to this process, these sensors could then clearly identify the disease 'biomarkers' – the tell-tale signs of diseased cells. Once the crystals are formed, their development and recognition actions can be detected by electrodes.

The presence of the crystals on the electrodes is detected as the signal of the bioassay which, for scientists, is a way of studying or picking up the signs of cell change: the stronger the signal – and the better the ability to 'sense' it – the greater the chances of detecting disease. That makes it sound simple, but this "bio-recognition and detection" is extremely complex, according to the team carrying out the research.

As MIMIC progressed, the project coordinator, Dr de la Rica made the decision to grow metal nanocrystals rather than the traditional calcium phosphate crystals as a way to generate a signal. These intensely coloured crystals possess outstanding optical properties and provide signals which are clearly readable or visible with standard lab instruments and even the naked eye. This was one of several decisions aimed at bringing the complexity of the problem down to manageable steps.

The team also decided that with this new concept it would not be necessary to use a 'biopolymer', such as collagen, to grow the crystals. This meant the sensor design would be further simplified. "There is also no need for the electrodes or other expensive equipment because the signal can be seen without them. Apart from this, the rest of the concept remains the same," Dr de la Rica says.

Catching disease early

Dr de la Rica explains that while MIMIC's work does not improve cancer treatment per se, it can improve its diagnosis. "Since it can detect cancer-related molecules at ultra-low concentrations, it might be possible to detect the tumour at a very early stage before it spreads and becomes a bigger threat," he notes.

The scientist reveals that the process has already shown potential in detecting cancer reoccurrence in prostate cancer patients. "Patients who have undergone total prostatectomy may benefit from ultra-sensitive systems that can detect the prostate-specific cancer biomarkers at much lower concentrations and provide early warning that the tumour is reappearing," he says.

The project's research has already attracted interest from industry. "The nano-detection systems proposed in MIMIC could be easily commercialised," confirms Dr de la Rica. Similarly, this also applies to the HIV identification method which also offers a much simpler and cheaper naked-eye-based read-out which could be commercialised and would enable much earlier diagnosis of the disease.

Writing in Nature Nanotechnology, Dr de la Rica and Professor Stevens also state that affordable methods for detecting disease biomarkers at ultra-low concentrations can potentially improve the standard of living in countries lacking costly medical resources.

Current strategies for ultra-sensitive detection often require sophisticated instruments that may not be available in laboratories with fewer resources, they noted. "We circumvent this problem by introducing a signal-generation mechanism for biosensing that enables the detection of a few molecules of analyte with the naked eye."

The researchers' work has been reported in major scientific publications but has also attracted the attention of media outlets such as the BBC and Daily Mail in the UK. What's more, the strong commercial potential and ground-breaking nature of their work in both cancer and HIV could provide a valuable boost to the competitiveness of the EU in the fields of health care and nanotechnology.

Project details

  • Project acronym: MIMIC
  • Participants: United Kingdom
  • Project N° 273621
  • Total costs: € 212 092
  • EU contribution: € 212 092
  • Duration: March 2011 to February 2013

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Project web site

Project information on CORDIS

Contacts
Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center